The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
[2-(5-Imidazo[4,5-b]pyridin-3-yl-1H-indol-3-yl)-ethyl]-dimethyl-amine ID: ALA80189
Max Phase: Preclinical
Molecular Formula: C18H19N5
Molecular Weight: 305.39
Molecule Type: Small molecule
Associated Items:
Representations Canonical SMILES: CN(C)CCc1c[nH]c2ccc(-n3cnc4cccnc43)cc12
Standard InChI: InChI=1S/C18H19N5/c1-22(2)9-7-13-11-20-16-6-5-14(10-15(13)16)23-12-21-17-4-3-8-19-18(17)23/h3-6,8,10-12,20H,7,9H2,1-2H3
Standard InChI Key: SZSNAHWJFCIUBV-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 305.39Molecular Weight (Monoisotopic): 305.1640AlogP: 3.01#Rotatable Bonds: 4Polar Surface Area: 49.74Molecular Species: BASEHBA: 4HBD: 1#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0CX Acidic pKa: CX Basic pKa: 9.54CX LogP: 2.62CX LogD: 0.49Aromatic Rings: 4Heavy Atoms: 23QED Weighted: 0.63Np Likeness Score: -1.12
References 1. Macor JE, Blank DH, Desai K, Fox CB, Kenneth Koe B, Lebel LA, Post RJ, Schmidt AW, Schulz DW, Seymour PA. (1995) 5-cyano-1-[3-(N-methylpyrrolidin-2R-ylmethyl)indol-5-yl] benzimidazole (CP-161,242): A potent, centrally active 5-HT1D receptor agonist and benzodiazepine partial agonist, 5 (20): [10.1016/0960-894X(95)00417-R ] 2. Macor JE, Blake JF, Desai K, Post RJ, Schmidt AW. (1995) The discovery of a novel and potent benzodiazepine receptor pharmacophore, 5 (20): [10.1016/0960-894X(95)00418-S ]